Edward A. Hartshorn
- Geriatrics and Gerontology top 10%
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 7
- Drug-Induced Adverse Reactions 3
- Drug-Induced Hepatotoxicity and Protection 3
-
- Pharmacogenetics and Drug Metabolism 7
- Drug-Induced Adverse Reactions 3
- Drug-Induced Hepatotoxicity and Protection 3
-
- Pharmaceutical studies and practices 6
-
- Electroconvulsive Therapy Studies 5
- Epilepsy research and treatment 3
-
- Analytical Methods in Pharmaceuticals 4
-
- Computational Drug Discovery Methods 3
- Co-authors
- George R. BailieBen M. LomaestroAjay AnandMichael T. HagleyColleen BurnsDarrell HuliszMurray P. DucharmeJohn D. Grabenstein
- Journals
- Annals of Pharmacotherapy (9 papers)The Journal of Cardiovascular Nursing (1 paper)The Nurse Practitioner (1 paper)
- Partner nations
- United StatesBelgiumMexico
In The Last Decade
Edward A. Hartshorn
29 papers receiving 344 citations
Peers
Comparison fields: 5 of 89
- Geriatrics and Gerontology 36
- Pharmacology 67
- Nephrology 35
- Pharmacology 73
- Pediatrics, Perinatology and Child Health 75
Countries citing papers authored by Edward A. Hartshorn
This map shows the geographic impact of Edward A. Hartshorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward A. Hartshorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward A. Hartshorn more than expected).
Fields of papers citing papers by Edward A. Hartshorn
This network shows the impact of papers produced by Edward A. Hartshorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward A. Hartshorn. The network helps show where Edward A. Hartshorn may publish in the future.
Co-authorship network
The 11 scholars most cited alongside Edward A. Hartshorn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 1 | |
| 2 | 2005 | 6 | |
| 3 | 1993 | 64 | |
| 4 | 1993 | 34 | |
| 5 | 1992 | 5 | |
| 6 | 1992 | 83 | |
| 7 | 1991 | 69 | |
| 8 | 1990 | 11 | |
| 9 | Vasopressin in the treatment of diabetes insipidus. | 1988 | 1 |
| 10 | 1988 | 0 | |
| 11 | 1975 | 2 | |
| 12 | 1975 | 2 | |
| 13 | 1971 | 5 | |
| 14 | 1970 | 1 | |
| 15 | 1969 | 0 | |
| 16 | 1969 | 2 | |
| 17 | 1968 | 1 | |
| 18 | 1968 | 9 | |
| 19 | 1968 | 4 | |
| 20 | 1968 | 5 |
About Edward A. Hartshorn
Edward A. Hartshorn is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry, having authored 34 papers that have together received 382 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Pharmaceutical studies and practices (6 papers), Electroconvulsive Therapy Studies (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Drug-Induced Adverse Reactions (3 papers), Computational Drug Discovery Methods (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Epilepsy research and treatment (3 papers). The work is most often cited by research in Geriatrics and Gerontology (36 citations), Pharmacology (67 citations) and Nephrology (35 citations). Edward A. Hartshorn has collaborated with scholars based in United States, Belgium and Mexico. Frequent co-authors include George R. Bailie, Ben M. Lomaestro, Ajay Anand, Michael T. Hagley, Colleen Burns, Darrell Hulisz, Murray P. Ducharme, John D. Grabenstein, C. Lindsay DeVane and Gary M. Levin. Their work appears in journals such as Annals of Pharmacotherapy, The Journal of Cardiovascular Nursing and The Nurse Practitioner.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.